Profil
Jean-Michel Petit is currently the Chairman at Sud Ouest Capital Risque Innovation SAS, IRDInov SAS, and PALUMED SA. He is also a Director at LID Technologies SAS, GamaMabs Pharma SA, ffly4u SAS, FineHeart SA, EnobraQ SAS, IXALTIS SAS, Micropep Technologies SAS, TreeFrog Therapeutics SAS, Swallis Medical SAS, APSI 3D SAS, IRDI Capital Investissement SAS, and ADEMTECH SA. In the past, Mr. Petit worked as a Director at Telecom Design and IXO Private Equity SAS from 2003 to 2012.
He was also a Director at SuperSonic Imagine SA, an Independent Director at Advicenne SA, and a Director at Backbone SAS. Additionally, he served as a Member-Supervisory Board at Genticel SA. Mr. Petit completed his MBA from McGill University in 1997.
He also holds an undergraduate degree from École Nationale Supérieure de Chimie de Paris, which he obtained in 1989.
Furthermore, he received a graduate degree from the University of Montréal in 1995.
Postes actifs de Jean-Michel Petit
| Sociétés | Poste | Début |
|---|---|---|
IRDI Capital Investissement SAS
IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital invests in small to mid-sized companies located in France, primarily in Nouvelle Aquitaine and Occitanie. The firm focuses on a broad range of sectors and industries. It provides financing for pre-seed, seed, early stage, MBO, MBI, takeover, development and LBO transactions with investment size ranging from EUR 0.1 to 4 million. It acquires minority positions and participates in subsequent rounds. IRDI Capital Investissement SAS reorganized its operating segments on December 9, 2016, by combining IRDI with Soridec to form a new company called Irdi Soridec Gestion. | Private Equity Investor | 01/04/2003 |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services Specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications | Directeur/Membre du Conseil | - |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services Specializes in developing monoclonal antibodies | Directeur/Membre du Conseil | 01/06/2013 |
LID Technologies SAS
LID Technologies SAS Electrical ProductsProducer Manufacturing Designs, manufactures and develops wireless embedded electronic systems for automotive markets | Directeur/Membre du Conseil | - |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
FineHeart SA
FineHeart SA Pharmaceuticals: MajorHealth Technology Develops a miniaturized device of cardiac assistance | Directeur/Membre du Conseil | 01/02/2016 |
IRDInov SAS
IRDInov SAS Financial ConglomeratesFinance Functions as an investment holding company | Président | - |
Sud Ouest Capital Risque Innovation SAS
Sud Ouest Capital Risque Innovation SAS Investment ManagersFinance Acts as Venture Capital Fund | Président | - |
APSI 3D SAS | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Jean-Michel Petit
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Jean-Michel Petit
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
IRDI Capital Investissement SAS
IRDI Capital Investissement SAS Investment ManagersFinance IRDI Capital invests in small to mid-sized companies located in France, primarily in Nouvelle Aquitaine and Occitanie. The firm focuses on a broad range of sectors and industries. It provides financing for pre-seed, seed, early stage, MBO, MBI, takeover, development and LBO transactions with investment size ranging from EUR 0.1 to 4 million. It acquires minority positions and participates in subsequent rounds. IRDI Capital Investissement SAS reorganized its operating segments on December 9, 2016, by combining IRDI with Soridec to form a new company called Irdi Soridec Gestion. | Finance |
Sud Ouest Capital Risque Innovation SAS
Sud Ouest Capital Risque Innovation SAS Investment ManagersFinance Acts as Venture Capital Fund | Finance |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PALUMED SA
PALUMED SA Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products for the treatment of Alzheimer's disease | Health Technology |
Telecom Design
Telecom Design Specialty TelecommunicationsCommunications Develops telecommunication solutions | Communications |
ADEMTECH SA
ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services Specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications | Commercial Services |
IXO Private Equity SAS
IXO Private Equity SAS Investment ManagersFinance IXO Private Equity invests in small and mid sized companies companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. It also acquires majority and minority interest. | Finance |
SuperSonic Imagine SA
SuperSonic Imagine SA Medical SpecialtiesHealth Technology Develops and manufactures ultrasound systems & medical imaging devices | Health Technology |
LID Technologies SAS
LID Technologies SAS Electrical ProductsProducer Manufacturing Designs, manufactures and develops wireless embedded electronic systems for automotive markets | Producer Manufacturing |
Genticel SA
Genticel SA BiotechnologyHealth Technology Develops vaccines for patients infected with human papillomavirus | Health Technology |
Advicenne SA
Advicenne SA Pharmaceuticals: GenericHealth Technology Develops and markets pediatric drugs | Health Technology |
GamaMabs Pharma SA
GamaMabs Pharma SA Medical/Nursing ServicesHealth Services Specializes in developing monoclonal antibodies | Health Services |
École Nationale Supérieure de Chimie de Paris
École Nationale Supérieure de Chimie de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ffly4u SAS
ffly4u SAS Specialty TelecommunicationsCommunications Provides a low frequency localization services for mobile assets. | Communications |
FineHeart SA
FineHeart SA Pharmaceuticals: MajorHealth Technology Develops a miniaturized device of cardiac assistance | Health Technology |
EnobraQ SAS
EnobraQ SAS Chemicals: Major DiversifiedProcess Industries Develops yeast for the production of chemical compounds | Process Industries |
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Backbone SAS
Backbone SAS Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets implantable medical devices for spine surgery | Health Technology |
MicroPEP Technologies SAS
MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services Provides natural crop protection research laboratory services | Commercial Services |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company | Commercial Services |
Swallis Medical SAS
Swallis Medical SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical and natural sciences | Commercial Services |
IRDInov SAS
IRDInov SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
APSI 3D SAS |
















